HCU Network America and HCU Network Australia: Research Grants in newborn screening and homocystinuria (EOI)

Key priorities for EOIs to be considered include:

• New therapies to treat classical homocystinuria and remethylation disorders by exploring novel mechanisms to obtain proof of concept to enable progression to clinical trials
• Technologies to improve early detection of classical homocystinuria and remethylation disorders, particularly via primary markers for newborn screening

Funding: $40,000. No overhead.

https://hcunetworkamerica.org/research-grants/